Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.64 +0.13 (+2.88%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.67 +0.03 (+0.65%) 18:55 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.30
Day High
4.69
Open 4.43
Previous Close 4.51 4.51
Volume 1,027,100 1,027,100
Avg Vol 1,618,095 1,618,095
Stochastic %K 52.80% 52.80%
Weighted Alpha -40.40 -40.40
5-Day Change +0.27 (+6.18%) +0.27 (+6.18%)
52-Week Range 3.72 - 12.61 3.72 - 12.61
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 543,093
  • Shares Outstanding, K 113,856
  • Annual Sales, $ 0 K
  • Annual Income, $ -255,860 K
  • EBIT $ -276 M
  • EBITDA $ -281 M
  • 60-Month Beta 1.67
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.52

Options Overview Details

View History
  • Implied Volatility 233.41% ( +32.17%)
  • Historical Volatility 87.81%
  • IV Percentile 98%
  • IV Rank 63.70%
  • IV High 359.83% on 04/07/25
  • IV Low 11.59% on 09/12/24
  • Put/Call Vol Ratio 15.00
  • Today's Volume 32
  • Volume Avg (30-Day) 433
  • Put/Call OI Ratio 3.08
  • Today's Open Interest 8,305
  • Open Int (30-Day) 5,647

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.55
  • Number of Estimates 5
  • High Estimate -0.44
  • Low Estimate -0.65
  • Prior Year -0.62
  • Growth Rate Est. (year over year) +11.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.72 +24.73%
on 04/09/25
Period Open: 6.90
6.93 -33.09%
on 03/26/25
-2.26 (-32.75%)
since 03/25/25
3-Month
3.72 +24.73%
on 04/09/25
Period Open: 8.35
10.15 -54.29%
on 01/30/25
-3.71 (-44.43%)
since 01/24/25
52-Week
3.72 +24.73%
on 04/09/25
Period Open: 6.01
12.61 -63.20%
on 10/23/24
-1.37 (-22.80%)
since 04/25/24

Most Recent Stories

More News
Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders

COGT : 4.64 (+2.88%)
Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting

COGT : 4.64 (+2.88%)
Is Cogent Biosciences (COGT) Stock a Solid Choice Right Now?

One stock that might be an intriguing choice for investors right now is Cogent Biosciences, Inc. COGT. This is because this security in the Medical - Biomedical and Genetics space is seeing solid earnings...

COGT : 4.64 (+2.88%)
Cogent Biosciences Announces Participation in the Leerink Healthcare Conference

COGT : 4.64 (+2.88%)
Cogent Biosciences Announces SUMMIT Continues to Showcase Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients

COGT : 4.64 (+2.88%)
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

COGT : 4.64 (+2.88%)
Cogent Biosciences Announces Bezuclastinib Poster in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2025 AAAAI Annual Meeting

COGT : 4.64 (+2.88%)
Cogent Biosciences to Participate in the Guggenheim Biotech Conference

COGT : 4.64 (+2.88%)
Cogent Biosciences Announces Planned 2025 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics

COGT : 4.64 (+2.88%)
Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

COGT : 4.64 (+2.88%)

Business Summary

Cogent Biosciences Inc. is a biotechnology company. It is focused on developing precision therapies for genetically defined diseases. The company's program consist PLX9486. Cogent Biosciences Inc., formerly known as Unum Therapeutics Inc., is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 5.16
2nd Resistance Point 4.92
1st Resistance Point 4.78
Last Price 4.64
1st Support Level 4.40
2nd Support Level 4.16
3rd Support Level 4.02

See More

52-Week High 12.61
Fibonacci 61.8% 9.21
Fibonacci 50% 8.16
Fibonacci 38.2% 7.12
Last Price 4.64
52-Week Low 3.72

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective